{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:17:19Z","timestamp":1788175039911,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jchromb.2023.123760","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T20:57:51Z","timestamp":1684789071000},"page":"123760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Simultaneous determination of maltol and maltol glucuronide in human plasma and urine by HPLC\u2013MS\/MS: Application in clinical study in patients with iron deficiency"],"prefix":"10.1016","volume":"1225","author":[{"given":"Zhengwen","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoyun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7A","key":"10.1016\/j.jchromb.2023.123760_b0005","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.amjmed.2003.12.011","article-title":"Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature","volume":"116","author":"Wilson","year":"2004","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jchromb.2023.123760_b0010","doi-asserted-by":"crossref","unstructured":"T. Greuter, S.R. Vavricka, Diagnosis and management of iron deficiency in inflammatory bowel disease, Nutritional Management of Inflammatory Bowel Diseases: A Comprehensive Guide, Springer International Publishing (2016), pp. 53-64.","DOI":"10.1007\/978-3-319-26890-3_4"},{"issue":"2","key":"10.1016\/j.jchromb.2023.123760_b0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.semnephrol.2016.02.001","article-title":"Iron balance and the role of hepcidin in chronic kidney disease","volume":"36","author":"Ganz","year":"2016","journal-title":"Semin. Nephrol."},{"issue":"9","key":"10.1016\/j.jchromb.2023.123760_b0020","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1046\/j.1365-2036.1998.00380.x","article-title":"Ferric trimaltol corrects iron deficiency anaemia in patients intolerant of iron","volume":"12","author":"Harvey","year":"1998","journal-title":"Aliment Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.jchromb.2023.123760_b0025","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1053\/j.ajkd.2021.03.020","article-title":"Oral Ferric Maltol for the Treatment of Iron-Deficiency Anemia in Patients With CKD: A Randomized Trial and Open-Label Extension","volume":"78","author":"Pergola","year":"2021","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"10.1016\/j.jchromb.2023.123760_b0030","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1053\/j.ackd.2019.05.002","article-title":"Novel oral iron therapies for iron deficiency anemia in chronic kidney disease","volume":"26","author":"Pergola","year":"2019","journal-title":"Adv. Chronic Kidney Dis."},{"issue":"19","key":"10.1016\/j.jchromb.2023.123760_b0035","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.3390\/jcm10194448","article-title":"Iron replacement therapy with oral ferric maltol: review of the evidence and expert opinion","volume":"10","author":"Schmidt","year":"2021","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.jchromb.2023.123760_b0040","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/MIB.0000000000000314","article-title":"Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program","volume":"21","author":"Gasche","year":"2014","journal-title":"Inflamm Bowel. Dis."},{"issue":"6","key":"10.1016\/j.jchromb.2023.123760_b0045","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s40267-016-0310-9","article-title":"Ferric maltol in iron deficiency anaemia in patients with inflammatory bowel disease: a guide to its use","volume":"32","author":"Lyseng-Williamson","year":"2016","journal-title":"Drugs Ther. Perspect."},{"key":"10.1016\/j.jchromb.2023.123760_b0050","unstructured":"Feraccru 30 mg hard capsules: summary of product characteristic, London: European Medicines Agency, 2016 https:\/\/www.medicines.org.uk\/emc\/medicine\/31722."},{"issue":"4","key":"10.1016\/j.jchromb.2023.123760_b0055","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/000456320003700405","article-title":"Assessment of iron absorption from ferric trimaltol","volume":"37","author":"Reffitt","year":"2000","journal-title":"Ann. Clin. Biochem."},{"issue":"3","key":"10.1016\/j.jchromb.2023.123760_b0060","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.2042-7158.1987.tb06249.x","article-title":"Effects of the pyrones, maltol and ethyl maltol, on iron absorption from the rat small intestine","volume":"39","author":"Barrand","year":"1987","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.jchromb.2023.123760_b0065","doi-asserted-by":"crossref","first-page":"S541","DOI":"10.1093\/ecco-jcc\/jjab076.713","article-title":"Costs savings associated with ferric maltol and the reduced use of intravenous iron based on real world data","volume":"15","author":"Howaldt","year":"2021","journal-title":"J. Crohns Colitis"},{"issue":"1","key":"10.1016\/j.jchromb.2023.123760_b0070","doi-asserted-by":"crossref","first-page":"S478","DOI":"10.1093\/ecco-jcc\/jjz203.695","article-title":"Impact of oral ferric maltol and IV iron on health-related quality of life in patients with iron deficiency anaemia and inflammatory bowel disease, and relationship with haemoglobin and serum iron","volume":"14","author":"Howaldt","year":"2020","journal-title":"J. Crohns Colitis"},{"issue":"2","key":"10.1016\/j.jchromb.2023.123760_b0075","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/1060028020941014","article-title":"Ferric maltol: a new oral iron formulation for the treatment of iron deficiency in adults","volume":"55","author":"Khoury","year":"2020","journal-title":"Ann. Pharmacother."},{"issue":"4","key":"10.1016\/j.jchromb.2023.123760_b0080","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.2042-7158.1990.tb05407.x","article-title":"Lipid peroxidation effects of a novel iron compound, ferric maltol. A comparison with ferrous sulphate","volume":"42","author":"Singh","year":"1990","journal-title":"J. Pharm. Pharmacol."},{"issue":"7","key":"10.1016\/j.jchromb.2023.123760_b0085","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.3390\/nu13072269","article-title":"Oral ferric maltol does not adversely affect the intestinal microbiome of patients or mice, but ferrous sulphate does","volume":"13","author":"Mahalhal","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.jchromb.2023.123760_b0090","first-page":"A905","article-title":"Ferric tri-maltol gives effective iron delivery with low side effects in patients intolerant of ferrous preparations","volume":"114","author":"Reffitt","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jchromb.2023.123760_b0095","doi-asserted-by":"crossref","unstructured":"C. Schmidt, T. Ahmad, Z. Tulassay, D.C. Baumgart, B. Bokemeyer, S. Howaldt, A. Stallmach, C. Buning, A.S. Group, Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study, Aliment Pharmacol. Ther. 44(3) (2016) 259-270. 10.1111\/apt.13665.","DOI":"10.1111\/apt.13665"},{"issue":"3","key":"10.1016\/j.jchromb.2023.123760_b0100","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1476-5381.1991.tb12240.x","article-title":"Dissociation of a ferric maltol complex and its subsequent metabolism during absorption across the small intestine of the rat","volume":"102","author":"Barrand","year":"1991","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.jchromb.2023.123760_b0105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s13318-016-0334-5","article-title":"Randomized open-label phase 1 study of the pharmacokinetics of ferric maltol in inflammatory bowel disease patients with iron deficiency","volume":"42","author":"Bokemeyer","year":"2017","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.jchromb.2023.123760_b0110","doi-asserted-by":"crossref","first-page":"e090","DOI":"10.1097\/PG9.0000000000000090","article-title":"Safety, tolerability, and pharmacokinetics of oral ferric maltol in children with iron deficiency: phase 1 study","volume":"2","author":"Allen","year":"2021","journal-title":"JPGN Reports"},{"key":"10.1016\/j.jchromb.2023.123760_b0115","unstructured":"Food and Drug Administration (FDA), Guidance for Industry-Bioanalytical Method Validation, 2018. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/bioanalytical-method-validation-guidance-industry."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023223001708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023223001708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:10:52Z","timestamp":1761606652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023223001708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":23,"alternative-id":["S1570023223001708"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2023.123760","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous determination of maltol and maltol glucuronide in human plasma and urine by HPLC\u2013MS\/MS: Application in clinical study in patients with iron deficiency","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2023.123760","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"123760"}}